Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Shibajyoti, Ghosh"'
Autor:
Ankita Chatterjee, Akash Bararia, Debopriyo Ganguly, Pronoy Kanti Mondal, Paromita Roy, Sudeep Banerjee, Shibajyoti Ghosh, Sumit Gulati, Supriyo Ghatak, Bitan Kumar Chattopadhay, Priyadarshi Basu, Aniruddha Chatterjee, Nilabja Sikdar
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-19 (2022)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the leading cancers worldwide and has a poor survival, with a 5-year survival rate of only 8.5%. In this study we investigated altered DNA methylation associated with PDAC severity
Externí odkaz:
https://doaj.org/article/880e51587c55454288a322fb898212b5
Autor:
Gourab Saha, Richa Singh, Argha Mandal, Subrata Das, Esita Chattopadhyay, Prasun Panja, Paromita Roy, Navonil DeSarkar, Sumit Gulati, Supriyo Ghatak, Shibajyoti Ghosh, Sudeep Banerjee, Bidyut Roy, Saurabh Ghosh, Dipankar Chaudhuri, Neeraj Arora, Nidhan K. Biswas, Nilabja Sikdar
Publikováno v:
Molecular Medicine, Vol 26, Iss 1, Pp 1-21 (2020)
Abstract Background Pancreatic Ductal Adenocarcinoma (PDAC) is a cancer of the exocrine pancreas and 5-year survival rates remain constant at 7%. Along with PDAC, Periampullary Adenocarcinoma (PAC) accounts for 0.5–2% of all gastrointestinal malign
Externí odkaz:
https://doaj.org/article/e23c79dfd1eb48aaa7793cdf3bab7cd1
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:CGE22-095
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6487b12ba27babc242f4f73b136a5f7
https://doi.org/10.6004/jnccn.2021.7157
https://doi.org/10.6004/jnccn.2021.7157
Autor:
Suvashis Dash, Shibajyoti Ghosh
Publikováno v:
Bulletin of Emergency and Trauma, Vol 5, Iss Issue 4, Pp 311-313 (2017)
Diabetes insipidus is a disease charaterised by increased urine production and thrist. Neurogenic diabetes insipidus following head trauma,autoimmune disease and infection is quite common but diabetes insipidus following thermal burn injury is a rare
Externí odkaz:
https://doaj.org/article/97e3ed6626694a3c99e7b00a830cb91d
Publikováno v:
Indian Journal of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::327b0e9811f3b19ca03747b6e1da6444
https://doi.org/10.1007/s13193-022-01685-6
https://doi.org/10.1007/s13193-022-01685-6
Autor:
Dweik, Majed, Stringer, R. Cody, Dastider, Shibajyoti Ghosh, Wu, Yifan, Almasri, Mahmoud, Barizuddin, Syed
Publikováno v:
In Talanta 30 May 2012 94:84-89
Autor:
Supriyo Ghatak, Sumit Gulati, Sudeep Banerjee, Akash Bararia, Subhankar Dey, Nilabja Sikdar, Shibajyoti Ghosh
Publikováno v:
Hepatobiliary & Pancreatic Diseases International. 19:205-217
Background Pancreatic cancer is one of the most lethal diseases with an incidence almost equal to the mortality. In addition to having genetic causes, cancer can also be considered an epigenetic disease. DNA methylation is the premier epigenetic modi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f540f0f1f2de4a05a71d23624870abc
https://doi.org/10.1016/j.hbpd.2020.03.010
https://doi.org/10.1016/j.hbpd.2020.03.010
Autor:
R. S. Katiyar, Abhishek Kumar, Srikant Ghosh, Amarjeet Bisla, Praveen Singh, Rupali Rautela, N. Srivastava, Shibajyoti Ghosh, Vinay Yadav
Publikováno v:
Inorganic and Nano-Metal Chemistry. 50:1103-1114
Since ensuring stability of the nanoparticles in aqueous-phase is essential for biomedical applications, this study evaluated the effect of ultra-sonication followed by peptization on iron-oxide na...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0ffbcb5f24fb50271a8d679690a7609
https://doi.org/10.1080/24701556.2020.1735426
https://doi.org/10.1080/24701556.2020.1735426
Autor:
Ankita Chatterjee, Akash Bararia, Debopriyo Ganguly, Paromita Roy, Sudeep Banerjee, Shibajyoti Ghosh, Sumit Gulati, Supriyo Ghatak, Bitan Kumar Chattopadhay, Arindam Maitra, Priyadarshi Basu, Aniruddha Chatterjee, Nilabja Sikdar
BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the leading cancers worldwide and has a poor survival, with a relative five-year survival rate of only 8.5%. In this study we investigated epigenetic marksassociated with PDAC severity and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d775204455f3890fc8608f4661c3ee84
https://doi.org/10.1101/2021.06.14.448193
https://doi.org/10.1101/2021.06.14.448193
Autor:
Navonil DeSarkar, Sumit Gulati, Nidhan K. Biswas, Supriyo Ghatak, Subrata K. Das, Argha Mandal, Neeraj Arora, Saurabh Ghosh, Gourab Saha, Nilabja Sikdar, Bidyut Roy, Paromita Roy, Esita Chattopadhyay, Richa Singh, Dipankar Chaudhuri, Prasun Panja, Shibajyoti Ghosh, Sudeep Banerjee
Publikováno v:
Molecular Medicine
Molecular Medicine, Vol 26, Iss 1, Pp 1-21 (2020)
Molecular Medicine, Vol 26, Iss 1, Pp 1-21 (2020)
Background Pancreatic Ductal Adenocarcinoma (PDAC) is a cancer of the exocrine pancreas and 5-year survival rates remain constant at 7%. Along with PDAC, Periampullary Adenocarcinoma (PAC) accounts for 0.5–2% of all gastrointestinal malignancies. G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d45d14446e79fd4ed57390254226dde
http://europepmc.org/articles/PMC7302128
http://europepmc.org/articles/PMC7302128